Literature DB >> 21733740

Role of voriconazole in combined acanthamoeba and fungal corneal ulcer.

Shikha Gupta1, Rajat Mohan Shrivastava, Radhika Tandon, Varun Gogia, Prakashchand Agarwal, Gita Satpathy.   

Abstract

We report a case of a 21 year old male who presented with smear-proven fungal corneal ulcer in left eye, refractory to treatment with topical natamycin. Corneal smears and culture were taken along with anterior chamber tap for microbiological investigations and intracameral 1% voriconazole was injected followed by institution of oral as well as topical voriconazole drops. Corneal and aqueous smear as well as culture confirmed the presence of acanthamoeba. The keratitis responded favourably to voriconazole therapy which was instituted along with topical trophicidal drugs and anterior chamber became quiet by 7th day. The patient was slowly tapered from voriconazole and was off the drug by 6 months. At one year follow up, he continues to remain asymptomatic. The possibility exists that the fungal organisms had either partially or completely responded to natamycin eye drops and voriconazole therapy further inhibited their growth along with being highly efficacious in suppressing acanthamoeba trophozoites. Voriconazole may be specifically instrumental in corneal ulcers with coinfection of acanthamoeba and fungal organisms and preventing recrudescence of both. Normal saline wet mount and 10% KOH mount of paracentesis sample for suspicious cases of refractory corneal ulcers to specifically look for trophozoites in order to institute timely treatment are recommended. 2011 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21733740     DOI: 10.1016/j.clae.2011.06.004

Source DB:  PubMed          Journal:  Cont Lens Anterior Eye        ISSN: 1367-0484            Impact factor:   3.077


  6 in total

1.  Cysticidal activity of antifungals against different genotypes of Acanthamoeba.

Authors:  Alfonso Iovieno; Darlene Miller; Dolena R Ledee; Eduardo C Alfonso
Journal:  Antimicrob Agents Chemother       Date:  2014-07-07       Impact factor: 5.191

Review 2.  The Development of Drugs against Acanthamoeba Infections.

Authors:  Ruqaiyyah Siddiqui; Yousuf Aqeel; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

3.  Ocular Inserts of Voriconazole-Loaded Proniosomal Gels: Formulation, Evaluation and Microbiological Studies.

Authors:  Ghada Ahmed El-Emam; Germeen N S Girgis; Mohamed M Adel El-Sokkary; Osama Abd El-Azeem Soliman; Abd El Gawad H Abd El Gawad
Journal:  Int J Nanomedicine       Date:  2020-10-12

Review 4.  Combating Acanthamoeba spp. cysts: what are the options?

Authors:  Ayaz Anwar; Naveed Ahmed Khan; Ruqaiyyah Siddiqui
Journal:  Parasit Vectors       Date:  2018-01-09       Impact factor: 3.876

5.  Voriconazole in the successful management of a case of Acanthamoeba-Cladosporium keratitis.

Authors:  Anita Raghavan; Arjun Velayudhan Nair; Kavitha N; Narendran Venkatapathy; Ram Rammohan
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-16

6.  Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis.

Authors:  Sakshi Malhotra; Anubha Khare; Kanchan Grover; Inderbir Singh; Pravin Pawar
Journal:  J Pharm (Cairo)       Date:  2014-04-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.